Sunrest LifescienceNSE:SUNREST +4.71%50 Days Payable is 171.36 as of Mar. 2026, which is 2% below its 10-year median of 175.04. GuruFocus rates NSE:SUNREST with a GF Score™ of 50/100. The stock has 5 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 90.74% on this metric.
The historical rank and industry rank for Sunrest Lifescience's Days Payable or its related term are showing as below:
NSE:SUNREST'
s Days Payable Range Over the Past 10 Years
Min: 113.39 Med: 175.04 Max: 342.71
Current: 342.71
During the past 7 years, Sunrest Lifescience's highest Days Payable was 342.71. The lowest was 113.39. And the median was 175.04.
NSE:SUNREST's Days Payable is ranked better than 90.74% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.51
vs NSE:SUNREST: 342.71
Sunrest Lifescience's Days Payable
increased
from Sep. 2024 (104.27) to Mar. 2026 (171.36).
It may suggest that Sunrest Lifesciencedelayed paying its suppliers.
Sunrest Lifescience Days Payable Related Terms
Sunrest Lifescience Days Payable Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Days Payable distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sunrest Lifescience's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience (NSE:SUNREST) has a Days Payable of 171.36 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sunrest Lifescience and its competitors. This is near median its historical median of 175.04. Over the past decade, Sunrest Lifescience's Days Payable has ranged from 113.39 to 342.71. According to the industry distribution chart, Sunrest Lifescience ranks #56 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 9.3%.
Is Sunrest Lifescience's Days Payable too high?
Sunrest Lifescience's current Days Payable of 171.36 is near median its 10-year median of 175.04. Over the past 10 years, this metric has ranged from a low of 113.39 to a high of 342.71. The Healthcare Providers & Services industry median Days Payable is 57.51. Sunrest Lifescience's value of 171.36 is 198% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #56 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sunrest Lifescience has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #56 out of 605 companies for Days Payable. This places Sunrest Lifescience in the top 9% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.51. Sunrest Lifescience's value of 171.36 is 198% above this benchmark. Historically, Sunrest Lifescience's own Days Payable has ranged from 113.39 to 342.71 over the past decade. While the company's 10-year median is 175.04 vs. the industry median of 57.51, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.51, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current Days Payable of 171.36 is 198% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current Days Payable is 171.36, which is near median its own 10-year median of 175.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Days Payable of 171.36. The current Days Payable is 171.36, which is near median its 10-year median of 175.04 and 198% above the Healthcare Providers & Services industry median of 57.51. Sunrest Lifescience's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Days Payable is 171.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
50GF Score
Get the complete analysis for NSE:SUNREST
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
